| Literature DB >> 16154463 |
Elizabeth D Barnett1, Lin H Chen.
Abstract
Pretravel consultation before international adoption must encompass standard advice for those who travel, advice for those who are exposed to the newly adopted child, and information about caring for a new child during travel. Children who travel to meet siblings may need special accommodations before and during travel. Data on the health of internationally adopted children illustrate the risk of exposing family members and close contacts to some infectious diseases during or after international adoption. Parents, family members, and close contacts of the newly adopted child should be given advice to reduce their own and their child's risk. Targeted preadoption counseling, close attention to hygiene and safety advice, and prompt identification and treatment of infections lead to the safest and most trouble-free adoption travel experience.Entities:
Mesh:
Year: 2005 PMID: 16154463 PMCID: PMC7118974 DOI: 10.1016/j.pcl.2005.06.002
Source DB: PubMed Journal: Pediatr Clin North Am ISSN: 0031-3955 Impact factor: 3.278
On-line resources to guide families planning international adoption
| Web site | Highlight |
|---|---|
| International adoption booklet; information on US visa requirements; travel warnings | |
| General health information regarding international adoption | |
| Link to journal articles and recommendations on international adoption; link to numerous resources for parents and providers | |
| Travel clinic directory | |
| Travel health warning and precautions; outbreaks; travel health recommendations |
Vaccines for families adopting internationally
| Vaccines for those who travel | Standard dose/route | Comment |
|---|---|---|
| Update all childhood vaccines for any children in household | ||
| Routine vaccines for adults (administer as needed according to standard schedules and recommendations) | ||
| Hepatitis B | 1.0 mL IM, 3 doses at 0, 1, 6 months | |
| Influenza | 0.5 mL IM, according to season | |
| Measles, mumps, rubella | 0.5 mL SC, documented 2 doses separated by ≥1 month | |
| Pneumococcal polysaccharide | 0.5 mL SC or IM | |
| Polio | 0.5 mL SC | For travel to areas with transmission of polioviruses |
| Td or TdaP | 0.5 mL IM | |
| Varicella | 0.5 mL SC, 2 doses separated by 4–8 weeks | |
| Special vaccines for travel to high- or intermediate-risk areas | ||
| Hepatitis A | 1.0 mL adult/0.5 mL pediatric IM, 2 doses at 0, 6 months | |
| Typhoid | 0.5 mL IM or 4 capsules PO | |
| Travel to high-risk areas or required by destination | ||
| Japanese encephalitis | 0.5 mL ages 1–2, 1.0 mL ages ≥3 SC, 3 doses on days 0, 7, 30 | For travel to parts of Asia |
| Meningococcus | 0.5 mL SC | For travel to endemic and outbreak areas |
| Rabies | 1.0 mL IM, 3 doses on days 0, 7, 21 or 28 | For longer term travel, remote destinations |
| Yellow fever | 0.5 mL SC | For travel to parts of South America and Africa |
Abbreviations: IM, intramuscular; PO, by mouth; SC, subcutaneous; Td, tetanus diphtheria; TdaP, tetanus-diphtheria-acellular pertussis.
Vaccines for nontraveling family members and close contacts
| Vaccine | Standard dose/route |
|---|---|
| Update all childhood vaccines for any children in household | |
| Vaccines for adults (administer as needed according to standard schedules) | |
| Hepatitis A | 1.0 mL adult/0.5 mL pediatric IM, 2 doses at 0, 6 months |
| Hepatitis B | 2.0 mL IM, 3 doses at 0, 1, 6 months |
| Influenza | 0.5 mL IM, according to season |
| Measles, mumps, rubella | 0.5 mL SC, documented 2 doses separated by ≥1 month |
| Pneumococcal polysaccharide | 0.5 mL SC or IM |
| Td or TdaP | 0.5 mL IM |
| Varicella | 0.5 mL SC, 2 doses separated by 4–8 weeks |
Abbreviations: IM, intramuscular; SC, subcutaneous; Td, tetanus diphtheria; Tdap, tetanus-diphtheria-acellular pertussis.